By Sabela Ojea New York Attorney General Letitia James has secured a five-year agreement with Denmark-based Novo Nordisk to cap the price of insulin at $35.
By Dominic Chopping Novo Nordisk launched its hugely popular Wegovy injectable weight-loss drug in the U.K. Monday, despite continuing challenges the company.